SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Organics reports Profit after tax of Rs 31.74 Mln, in the March 2021 quarter

23 Apr 2021 Evaluate
A slight decline in the revenue of Rs. 287.19 millions was seen for the March 2021 quarter as against Rs. 299.83 millions during year-ago period.The Profit  for the quarter ended March 2021 of  Rs. 31.74  millions  grew by 65.14% from Rs. 19.22 millions.OP of the company witnessed a marginal growth to 56.42 millions from 52.24 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202103 202003 % Var 202103 202003 % Var 202003 201903 % Var
Sales 287.19 299.83 -4.22 1265.01 1310.74 -3.49 1310.74 1374.11 -4.61
Other Income 1.85 2.11 -12.32 5.61 44.21 -87.31 44.21 8.80 402.39
PBIDT 56.42 52.24 8.00 290.94 196.57 48.01 196.57 174.71 12.51
Interest 2.28 6.22 -63.34 10.94 31.80 -65.60 31.81 35.80 -11.15
PBDT 54.14 46.02 17.64 280.00 164.77 69.93 164.76 138.91 18.61
Depreciation 9.03 12.36 -26.94 39.47 43.86 -10.01 43.86 41.35 6.07
PBT 45.11 33.66 34.02 240.53 120.91 98.93 120.90 97.56 23.92
TAX 13.37 14.44 -7.41 69.47 36.44 90.64 36.44 28.95 25.87
Deferred Tax 2.94 2.86 2.80 1.42 6.66 -78.68 6.66 26.91 -75.25
PAT 31.74 19.22 65.14 171.06 84.47 102.51 84.46 68.61 23.10
Equity 114.46 38.15 200.03 114.46 38.15 200.03 38.15 38.15 0.00
PBIDTM(%) 19.65 17.42 12.75 23.00 15.00 53.36 15.00 12.71 17.95

Smruthi Organics Share Price

122.20 0.35 (0.29%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: